Identification of Amino Acid Residues of Anthrax Protective Antigen Involved in Binding with Lethal Factor

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Infection and Immunity

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/IAI.70.8.4477-4484.2002PMID 12117959PMCID PMC128118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli.

  2001cited by this paper
• Protein–protein interfaces: Analysis of amino acid conservation in homodimers

  2001cited by this paper
• Identification of the cellular receptor for anthrax toxin

  2001cited by this paper
• Crystal structure of the anthrax lethal factor

  2001cited by this paper
• Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.

  2001cited by this paper
• Expression and purification of the recombinant protective antigen of Bacillus anthracis.

  1999cited by this paper
• Anthrax protective antigen: prepore-to-pore conversion.

  1999cited by this paper
• Stability and folding of domain proteins.

  1999cited by this paper
• Characterization of membrane translocation by anthrax protective antigen.

  1998cited by this paper
• Predictive docking of protein-protein and protein-DNA complexes.

  1998cited by this paper
• Expression and Purification of the Recombinant Lethal Factor of Bacillus anthracis

  1998cited by this paper
• Studies of protein‐protein interfaces: A statistical analysis of the hydrophobic effect

  1997cited by this paper
• Crystal structure of the anthrax toxin protective antigen

  1997influential reference
• A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen

  1997cited by this paper
• More than one way to make a hole

  1997cited by this paper
• Modification of a PCR-based site-directed mutagenesis method.

  1997cited by this paper
• Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies.

  1996cited by this paper
• Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases

  1995cited by this paper
• Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

  1994cited by this paper
• Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity

  1994cited by this paper
• Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP

  1994cited by this paper
• Directional cloning of blunt-ended PCR products.

  1993cited by this paper
• Serum protease cleavage of Bacillus anthracis protective antigen.

  1992cited by this paper
• Purification and characterization of adenylyl cyclase from Bacillus anthracis.

  1991cited by this paper
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.

  1989cited by this paper
• A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.

  1989cited by this paper
• A simple method for site-directed mutagenesis using the polymerase chain reaction.

  1989cited by this paper
• Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases.

  1988cited by this paper
• Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

  1982cited by this paper
• Complementary action of restriction enzymes endo R-DpnI and Endo R-DpnII on bacteriophage f1 DNA.

  1977cited by this paper
• Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

  1962cited by this paper

• Toxin Transport by A-B Type of Toxins in Eukaryotic Target Cells and Its Inhibition by Positively Charged Heterocyclic Molecules.

  2017cites this paper
• Bacillus anthracis toxins

  2015cites this paper
• Recent Developments in Anti-dotes Against Anthrax.

  2014cites this paper
• Bacillus anthracis lethal toxin induces cell‐type‐specific cytotoxicity in human lung cell lines

  2014cites this paper
• Anthrax lethal toxin unfolding and translocation via a charge-state ratchet

  2013cites this paper
• Role of chondroitin sulfate C in the action of anthrax toxin.

  2012cites this paper
• Ratcheting up protein translocation with anthrax toxin

  2012cites this paper
• Molecular Mechanisms of Anthrax Toxin Assembly and Transport

  2012cites this paper
• Mechanisms of translocation-coupled protein unfolding using anthrax toxin as a model

  2011cites this paper
• Cloning and Expressing Recombinant Protective Antigen Domains of B. anthracis

  2011cites this paper
• A Femtomol Range FRET Biosensor Reports Exceedingly Low Levels of Cell Surface Furin: Implications for the Processing of Anthrax Protective Antigen

  2010cites this paper
• Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers

  2010cites this paper
• The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

  2009cites this paper
• Branched peptides as therapeutics.

  2008cites this paper
• Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

  2007cites this paper
• Model of the toxic complex of anthrax: Responsive conformational changes in both the lethal factor and the protective antigen heptamer

  2006cites this paper
• Anthrax vaccine powder formulations for nasal mucosal delivery.

  2006cites this paper
• Anthrax Edema Factor, Voltage-dependent Binding to the Protective Antigen Ion Channel and Comparison to LF Binding*

  2006cites this paper
• Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen

  2006cites this paper
• Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.

  2006cites this paper
• Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.

  2006cites this paper
• Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.

  2006cites this paper
• Bacillus anthracis: Agent of Bioterror and Disease

  2006cites this paper
• CHAPTER 18 – Bacillus anthracis toxins

  2006cites this paper
• Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.

  2005cites this paper
• Anthrax Biosensor, Protective Antigen Ion Channel Asymmetric Blockade*

  2005cites this paper
• Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.

  2004cites this paper
• Anthrax toxins.

  2004cites this paper
• The roles of anthrax toxin in pathogenesis.

  2004cites this paper
• Rho-modifying C3-like ADP-ribosyltransferases.

  2004cites this paper
• Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins

  2004cites this paper